Showing posts with label clinical trial. Show all posts
Showing posts with label clinical trial. Show all posts

Tuesday, 7 July 2020

Startup Funding Alert: Data analytics startup Evidation raises $45M, plots foray into virtual health


Evidation Health, a startup that provides technology for virtual clinical trials, raised $45 million in series D funding. The company plans to use the funds to offer virtual health programs to research participants.

The San Mateo-based company can pull in data from wearable devices, videos, speech, and other sources. It also designs virtual studies using this capability, such as Johnson & Johnson’s Heartline study, which tests whether an Apple watch feature can detect atrial fibrillation earlier and reduce participants’ stroke risks.

The company’s research app, Achievement, pays users to track steps, sleep, meals and other health metrics. They can also opt into participating in virtual clinical trials. Evidation Health says 4 million people that use the app.

Read on

Data analytics startup Evidation raises $45M, plots foray into virtual health

Evidation Health, a startup that pulls in digital health data for virtual studies, raised $45 million in funding. The San Mateo-based company can pull in data from wearable devices, videos, speech, and other sources. It also designs virtual studies using this capability, such as Johnson & Johnson's Heartline study, which tests whether an Apple watch feature can detect atrial fibrillation earlier and reduce participants' stroke risks.

Tuesday, 30 June 2020

Covi-19: Bharat Biotech's Covid vaccine gets DCGI nod for clinical trials


Indian vaccine manufacturer Bharat Biotech has announced obtaining the approvals of the Drug Controller General of India to initiate phase-I and II human clinical trials for the vaccine candidate for Covid-19 it developed in collaboration with the National Institute of Virology, part of the Indian Council of Medical Research.

Read on

Bharat Biotech's Covid vaccine gets DCGI nod for clinical trials

Indian vaccine manufacturer Bharat Biotech has announced obtaining the approvals of the Drug Controller General of India to initiate phase-I and II human clinical trials for the vaccine candidate for Covid-19 it developed in collaboration with the National Institute of Virology, part of the Indian Council of Medical Research.